Related Experiment Video
Updated: Mar 7, 2026
A Murine Model of Fetal Exposure to Maternal Inflammation to Study the Effects of Acute Chorioamnionitis on Newborn Intestinal Development
Published on: June 24, 2020
Maternal Infections That Would Warrant Antibiotic Use Antepartum or Peripartum Are Not a Risk Factor for the
Charles N Bernstein1, Charles Burchill, Laura E Targownik
1*Inflammatory Bowel Disease Clinical and Research Centre, Max Rady College of Medicine, Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada; †Department of Internal Medicine, Max Rady College of Medicine, Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada; ‡Manitoba Centre for Health Policy, Max Rady College of Medicine, Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada; and §Department of Community Health Sciences, Max Rady College of Medicine, Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada.
Background:
We aimed to determine whether maternal antenatal or perinatal infections (and thereby use of antibiotics) increase the risk of developing inflammatory bowel disease (IBD) in their offspring.
Methods:
The University of Manitoba IBD Epidemiology Database contains records of all Manitobans diagnosed with IBD from 1984 to 2010. Each individual with IBD is matched to 10 controls. Subjects' medical system contacts are identified using a unique deidentified personal health identification number. Individuals born in 1970 and later are linkable to their mothers through a 6-digit family health registration number and cross referencing of mothers' personal health identification number with the child's birth record. We assessed antenatal (30 days and 9 months before delivery) and peripartum (in hospital) maternal infections identified by ICD-8 and ICD-9 codes as a proxy for antibiotic use.
Results:
Of the 2487 IBD cases born after 1970, 1758 were born in Manitoba, of which 1671 were linkable to mothers (Crohn's disease = 973 and ulcerative colitis = 698). From 1615 families, 10488 matched controls and 1740 siblings were identified. Maternal infections occurred with equal rates in mothers of IBD cases and mothers of controls: within 9 months antepartum, 21.7% versus 23.2% (odds ratio = 0.96 [0.84-1.09]); within 30 days antepartum 11.4% versus 12.4% (odds ratio = 0.97, 0.82-1.14); peripartum 5.5% versus 7.5% (odds ratio = 0.86, 0.68-1.09). There was also no difference in the occurrence of antepartum or peripartum infections among mothers of IBD cases versus unaffected siblings.
Conclusions:
Maternal infections (and therefore antibiotic use) in the antepartum and peripartum periods do not affect the risk of development of IBD in offspring.
Related Concept Videos
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
01:30Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
01:17Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF